Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients

被引:96
|
作者
Hu, YY
He, SS
Wang, XC
Duan, QH
Khatoon, S
Iqbal, K
Grundke-Iqbal, I
Wang, JZ
机构
[1] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA
[2] Tongji Med Coll, HUST, Wuhan 430030, Peoples R China
关键词
Alzheimer disease; vascular dementia; neurofilament protein subunits; cerebrospinal fluid; enzyme-linked immunosorbent assay; bienzyme substrate-recycle enzyme-linked immunosorbent assay; biomarkers;
D O I
10.1016/S0304-3940(02)00047-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurofilament (NF) subunits NF-H, NF-M and NF-L are hyperphosphorylated and elevated in Alzheimer disease (AD) brain. We investigated the level and phosphorylation states of NF subunits in lumbar cerebrospinal fluid (CSF) from living patients by bienzyme substrate-recycle enzyme-linked immunosorbent assay. We found: (i), that the levels of phosphorylated NF-H/M (pNF-H/M), non-phosphorylated NF-H/M (npNF-H/M) and NF-L were significantly higher (pNF-H/ M, similar to12-24-fold; npNF-H/M, similar to3-4-fold) in neurologically healthy aged people than young control individuals; (ii), that in AD, the levels of npNF-H/M, and NF-L were similar to vascular dementia (VaD), and higher than in age-matched controls; and (iii), that the levels of pNF-H/M were significantly higher than in aged controls, non-AD neurological disorders and VaD. Based on these findings, it is suggested that the increased level of total NF proteins in CSF could be used as a marker for brain aging and neurodegenerative disorders in general, and the levels of pNF-H/M as a marker to discriminate AD from normal brain aging and as well as neurological conditions including VaD. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 50 条
  • [21] Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression
    Tortelli, R.
    Ruggieri, M.
    Cortese, R.
    D'Errico, E.
    Capozzo, R.
    Leo, A.
    Mastrapasqua, M.
    Zoccolella, S.
    Leante, R.
    Livrea, P.
    Logroscino, G.
    Simone, I. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (12) : 1561 - 1567
  • [22] ELEVATED LEVELS OF CATHEPSIN-D IN CEREBROSPINAL-FLUID FROM ALZHEIMER-DISEASE PATIENTS
    SCHWAGERL, AL
    MOHAN, PS
    CATALDO, AM
    KOWALL, NW
    NIXON, RA
    NEUROBIOLOGY OF AGING, 1994, 15 : S115 - S115
  • [23] Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy
    Toedebusch, C. M.
    Bachrach, M. D.
    Garcia, V. B.
    Johnson, G. C.
    Katz, M. L.
    Shaw, G.
    Coates, J. R.
    Garcia, M. L.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2017, 31 (02): : 513 - 520
  • [24] Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231
    Buerger, K
    Zinkowski, R
    Teipel, SJ
    Tapiola, T
    Arai, H
    Blennow, K
    Andreasen, N
    Hofmann-Kiefer, K
    DeBernardis, J
    Kerkman, D
    McCulloch, C
    Kohnken, R
    Padberg, F
    Pirttilä, T
    Schapiro, MB
    Rapoport, SI
    Möller, HJ
    Davies, P
    Hampel, H
    ARCHIVES OF NEUROLOGY, 2002, 59 (08) : 1267 - 1272
  • [25] Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients
    Kohnken, R
    Buerger, K
    Zinkowski, R
    Miller, C
    Kerkman, D
    DeBernardis, J
    Shen, JF
    Möller, HJ
    Davies, P
    Hampel, H
    NEUROSCIENCE LETTERS, 2000, 287 (03) : 187 - 190
  • [26] Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
    Zetterberg, Henrik
    Skillback, Tobias
    Mattsson, Niklas
    Trojanowski, John Q.
    Portelius, Erik
    Shaw, Leslie M.
    Weiner, Michael W.
    Blennow, Kaj
    JAMA NEUROLOGY, 2016, 73 (01) : 60 - 67
  • [27] Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
    Mattsson, Niklas
    Insel, Philip S.
    Palmqvist, Sebastian
    Portelius, Erik
    Zetterberg, Henrik
    Weiner, Michael
    Blennow, Kai
    Hansson, Oskar
    EMBO MOLECULAR MEDICINE, 2016, 8 (10) : 1184 - 1196
  • [28] Elevated cerebrospinal fluid tau levels: Implications for the early diagnosis of Alzheimer's disease
    Terajima, M
    Arai, H
    Itabashi, S
    Higuchi, M
    Zhu, CQ
    Kosaka, Y
    Nakagawa, T
    Sasaki, H
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (08) : 1012 - 1013
  • [29] NEUROCYTOSKELETAL PROTEINS IN CEREBROSPINAL FLUID AND SERUM IN PATIENTS WITH ALZHEIMER'S DISEASE
    Bartos, A.
    Svarcova, J.
    Cechova, L.
    Lenka, F.
    Malbohan, I.
    Ripova, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 347 - 347
  • [30] Reduced Levels of Amyloid-β-Binding Proteins in Cerebrospinal Fluid from Alzheimer's Disease Patients
    Hansson, Sara F.
    Andreasson, Ulf
    Wall, Mariann
    Skoog, Ingmar
    Andreasen, Niels
    Wallin, Anders
    Zetterberg, Henrik
    Blennow, Kaj
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (02) : 389 - 397